BELLEVUE GROUP AG – Mersana Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$27.59M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.81% | 187.4K shares | 9.60M | $6.76 | 4.08M |
| Q2 2022 | share | Decrease | -1.49% | -58.8K shares | 2.21M | $4.62 | 3.89M |
| Q1 2022 | share | Decrease | -5.04% | -210K shares | -10.12M | $3.99 | 3.95M |
| Q4 2021 | share | Decrease | -2.28% | -97K shares | -14.28M | $6.4 | 4.16M |
| Q3 2021 | share | Increase | +44.88% | 1.32M shares | 242K | $9.43 | 4.26M |
| Q2 2021 | share | Increase | +3.19% | 90.99K shares | -6.17M | $13.58 | 2.94M |
| Q1 2021 | share | Increase | +47.97% | 924K shares | -5.13M | $16.18 | 2.85M |
| Q4 2020 | share | Increase | 0.00% | 1.92M shares | 51.25M | $26.61 | 1.92M |